Literature DB >> 465353

The heterogeneity of normal Hb A2-beta thalassaemia in Greece.

C Kattamis, A Metaxotou-Mavromati, W G Wood, J R Nash, D J Weatherall.   

Abstract

Nine patients have been observed with homozygous beta thalassaemia in each of whom one parent has a normal level of Hb A2. On the basis of clinical, haematological and globin chain synthesis studies these families have been divided into two groups. Group 1 (six families). Heterozygotes for normal Hb A2-beta thalassaemia in this group showed minimal red cell abnormalities, normal osmotic fragility but imbalanced globin chain synthesis (alpha/beta=1.6), and appear to correspond to previous descriptions of 'silent' beta thalassaemia. Double heterozygotes with high Hb A2-beta thalassaemia have a clinical picture of mild beta thalassaemia intermedia characterized by relatively low levels of Hb F (less than 20%) and gamma chain synthesis. Group 2 (three families). beta Thalassaemia heterozygotes with normal HbA2 levels in this group showed more marked red cell abnormalities, decreased osmotic fragility and more imbalanced globin chain synthesis (alpha/beta=2.5) than those in group I. Double heterozygotes with high Hb A2-beta thalassaemia are more severely affected and are transfusion dependent. Haemoglobin F and gamma chain synthesis are high in these cases. The frequency of normal Hb A2-beta thalassaemia in Greece may be as high as 10% of all beta thalassaemia genes and this poses a significant problem for genetic counselling. Various molecular mechanisms are discussed which could account for the heterogeneity within these disorders.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 465353     DOI: 10.1111/j.1365-2141.1979.tb03703.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  10 in total

1.  Age, beta thalassaemia trait, and iron-deficient anaemia significantly affect reticulocyte indices in pre-school children.

Authors:  Giorgos L Chouliaras; Alexandra Stamoulakatou; George Tsiftis; Georgia Perissaki; Evangelos Premetis; Lilia Lycopoulou
Journal:  Eur J Pediatr       Date:  2010-03-25       Impact factor: 3.183

2.  Clinical heterogeneity of silent-gene b-thalassemia among Indians.

Authors:  A Nadkarni; A Pawar; V C Mudera; D Mohanty; R Colah
Journal:  Ann Hematol       Date:  1995-01       Impact factor: 3.673

3.  A genetic combination of silent beta-thalassaemia, high Hb A2 beta-thalassaemia, and single alpha globin gene deletion causing mild thalassaemia intermedia.

Authors:  R Galanello; L Maccioni; M C Rosatelli; P Ibba; A M Nurchi; A Cao
Journal:  J Med Genet       Date:  1984-04       Impact factor: 6.318

4.  beta+-Thalassemia intermedia with low HbF.

Authors:  M A Zago; F F Costa; C Bottura
Journal:  Klin Wochenschr       Date:  1983-01-17

5.  Effectiveness of one tube osmotic fragility screening in detecting beta-thalassaemia trait.

Authors:  C Kattamis; G Efremov; S Pootrakul
Journal:  J Med Genet       Date:  1981-08       Impact factor: 6.318

6.  Clinical, haematological, and genetic studies of type 2 normal Hb A2 beta thalassaemia.

Authors:  A Metaxotou-Mavromati; C Kattamis; L Matathia; M Tzetis; E Kanavakis
Journal:  J Med Genet       Date:  1988-03       Impact factor: 6.318

7.  Thalassaemia intermedia in a family with beta 0-thalassaemia and Hb Hasharon.

Authors:  M A Zago; F F Costa; C Bottura
Journal:  J Med Genet       Date:  1982-12       Impact factor: 6.318

8.  The clinical phenotype of beta and delta beta thalassemias in Greece.

Authors:  C Kattamis; A Metaxotou-Mavromati; V Ladis; H Tsiarta; S Laskari; E Kanavakis
Journal:  Eur J Pediatr       Date:  1982-10       Impact factor: 3.183

Review 9.  The prevention of thalassemia.

Authors:  Antonio Cao; Yuet Wai Kan
Journal:  Cold Spring Harb Perspect Med       Date:  2013-02-01       Impact factor: 6.915

10.  Heterozygosity of the Complex Corfu δ0β+ Thalassemic Allele (HBD Deletion and HBB:c.92+5G>A) Revisited.

Authors:  Christos Kattamis; Myrto Skafida; Polyxeni Delaporta; Christina Vrettou; Joanne Traeger-Synodinos; Christalena Sofocleous; Antonis Kattamis
Journal:  Biology (Basel)       Date:  2022-03-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.